Cancer Profiling Market Will Attain a Value of USD 16.6 billion by 2025 – ZMR News Blog

Cancer Profiling Market Will Attain a Value of USD 16.6 billion by 2025

Zion Market Research has published a new report titled “Cancer Profiling Market by Technique (Genomics, Proteomics, Metabolomics, and Epigenetics), by Technology (Immunoassay, Hybridization, Next-Generation Sequencing, Mass Spectroscopy, and Others), by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), and by Application (Personalized Cancer Medicine, Oncological Diagnostics, Research, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global cancer profiling market was valued at approximately USD 8.58 billion in 2018 and is expected to generate around USD 16.6 billion by 2025, at a CAGR of around 9.9% between 2019 and 2025.

The uncontrolled growth of cells due to the defect in the process of cell growth cycle leads to cancer. Cancer may be malignant or benign. Initially, cancer is in a tumor state, where it has lesser chances of spreading to different parts of the body. Cancer profiling or tumor profiling is a technique used to determine the genetic makeup of cancerous cells. The rise in the adoption of cancer biomarkers for cancer profiling, increase in the number of research activities for cancer treatments, development of various cancer diagnostics techniques, and growth in investments made by governments and other institutions for cancer research and demand for personalized medicines in developed countries are driving the global cancer profiling market.

Get Brochure of this Cancer Profiling Market @

The global cancer profiling market is divided into technique, technology, cancer type, and application. By technique, the market for cancer profiling includes genomics, epigenetics, proteomics, and metabolomics. Genomics dominated the cancer profiling market in 2018, owing to its cost-effectiveness and improved screen time. The genomics technique is directly used to detect the genetic variations in cancerous cells.

Based on technology, the cancer profiling market includes in situ hybridization, PCR, immunohistochemistry, microarray, next-generation sequencing, and others. The next-generation sequencing dominated the cancer profiling market globally in 2018, owing to the rapid developments witnessed in this process and the easy availability of this technology.

By cancer type, the cancer profiling market includes prostate cancer, melanoma cancer, breast cancer, colorectal cancer, lung cancer, and others. The growing prevalence of breast cancer among women is mainly fueling the breast cancer segment. According to the World Cancer Research Fund, in 2018, about 2 million new breast cancer cases were registered worldwide.

For More Details Get Sample Pages of this Report

Based on application, the cancer profiling market includes personalized medicine, oncological diagnostics, research, and others. Personalized medicine is anticipated to show high growth in the future, due to the growing awareness about the advantages of personalized medicines in developed countries and the rising number of research and development activities for personalized medicine.

By region, North America dominated the global market in 2018 owing to high cancer prevalence, developed healthcare infrastructure, and an increase in the number of cancer-related research activities. Asia Pacific is expected to show the highest CAGR in the upcoming years, owing to the growing cancer prevalence in developing countries like India and China, rising investments by companies and governments in cancer research, and increasing awareness about cancer profiling techniques.

Inquire more or share questions if any before the purchase on this report @

Some key players of the global cancer profiling market are HTG Molecular Diagnostic, Illumina, NeoGenomics Laboratories, QIAGEN, Caris Life Sciences, Helomics Corporation, Oxford Gene Technology, Genomic Health, NanoString Technologies, and RiboMed Biotechnologies.

This report segments the global cancer profiling market as follows:

Global Cancer Profiling Market: Technique Analysis

  • Genomics
  • Proteomics
  • Metabolomics
  • Epigenetics

Global Cancer Profiling Market: Technology Analysis

  • Immunoassay
  • Hybridization
  • Next-Generation Sequencing
  • Mass Spectroscopy
  • Others

Global Cancer Profiling Market: Cancer Type Analysis

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Melanoma Cancer

Comments are closed, but trackbacks and pingbacks are open.